Joel Farley, PhD

Department of Pharmaceutical Care & Health Systems, College of Pharmacy, University of Minnesota, Minnesota, USA

Poster(s):

• (252) Comparative effectiveness of sodium-glucose co-transporter 2 inhibitors vs dipeptidyl peptidase 4 inhibitors on liver outcomes in patients with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST